2387-08-8Relevant articles and documents
PYRROLOPYRAZINE KINASE INHIBITORS
-
Page/Page column 187; 188, (2013/03/28)
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
CYCLIC AMIDINES USEFUL AS NMDA NR2B ANTAGONISTS
-
, (2008/06/13)
The invention encompasses novel compounds of Formula I as well as a method of treating NMDA mediated diseases comprising administration to a patient in need of such treatment a non-toxic amount of a compound of Formula I effective to block the NMDA NR2B r